Max Foundation, ABC Global Alliance, American Society of Clinical Pathology, Cepheid, Novartis AG collaborate to improve advanced breast cancer outcomes in low-resource countries

Breast implant closes reconstruction gap for patients after mastectomy

Johnson & Johnson MedTech on May 13 announced the U.S. launch of MENTOR MemoryGel Enhance Breast Implants, filling a critical gap in comprehensive breast cancer care for women who have undergone a mastectomy.

May 16, 2025

Vol.51 No.19

Clinical Roundup

Incidence rates of some cancer types have risen in people under age 50, NCI study shows

Researchers at NCI have completed a comprehensive analysis of cancer statistics for different age groups in the United States and found that from 2010 through 2019, the incidence of 14 cancer types increased among people under age 50.

May 09, 2025

Vol.51 No.18

Cancer Policy

NIH notice prohibits grant awardees from operating programs that promote DEI

NIH, in a recent notice, prohibits grant recipients from operating programs that promote DEI or “discriminatory equity ideology,” or engage in “discriminatory prohibited boycott.”

Federal judges rule that Department of Education policy ordering universities to end DEI programs a violation of educators’ free speech

Federal judges in Maryland, New Hampshire and Washington, DC, blocked the Trump administration from following through on threats to cut off funding to universities that engage in DEI efforts.

Enhertu demonstrates superior efficacy over standard of care in HER2+ metastatic breast cancer

The DESTINY-Breast09 phase III trial of AstraZeneca and Daiichi Sankyo’s Enhertu is the first trial in more than a decade to demonstrate superior efficacy across a broad HER2-positive metastatic patient population versus current first-line standard of care.

April 25, 2025

Vol.51 No.16

In Brief

Hope Rugo named director of City of Hope’s Women’s Cancers Program

Hope S. Rugo has joined City of Hope to lead its Women’s Cancers Program throughout the organization and breast medical oncology division section.

April 18, 2025

Vol.51 No.15

Max Foundation, ABC Global Alliance, American Society of Clinical Pathology, Cepheid, Novartis AG collaborate to improve advanced breast cancer outcomes in low-resource countries

YOU MAY BE INTERESTED IN

Breast implant closes reconstruction gap for patients after mastectomy

Incidence rates of some cancer types have risen in people under age 50, NCI study shows

NIH notice prohibits grant awardees from operating programs that promote DEI

Federal judges rule that Department of Education policy ordering universities to end DEI programs a violation of educators’ free speech

Enhertu demonstrates superior efficacy over standard of care in HER2+ metastatic breast cancer

Hope Rugo named director of City of Hope’s Women’s Cancers Program

Renew today!

Subscriber content

Never miss an issue!

Login